COVID-19: A Possible Contribution of the MAPK Pathway.
Jessica CusatoAlessandra MancaAlice PalermitiJacopo MulaMartina CostanzoMiriam AntonucciMattia TrunfioSilvia CorcioneFrancesco ChiaraElisa Delia De VivoAlice IannielloMicol FerraraGiovanni Di PerriFrancesco Giuseppe De RosaAntonio D'AvolioAndrea CalcagnoPublished in: Biomedicines (2023)
This is the first study that showed a possible contribution of MAPK-related biomarkers in affecting COVID-19 clinical features, and this may be relevant for identifying COVID-19 positive participants at risk of serious complications.